⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLYM News
Climb Bio, Inc. Common Stock
Form 8-K
sec.gov
CLYM
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
CLYM
Climb Bio to Present at Upcoming Investor Conferences
globenewswire.com
CLYM
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
globenewswire.com
CLYM
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CLYM
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
globenewswire.com
CLYM
Climb Bio to Present at Upcoming Investor Conferences
globenewswire.com
CLYM
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
globenewswire.com
CLYM
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
globenewswire.com
CLYM
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
globenewswire.com
CLYM